What is Enzymit?
Enzymit is at the forefront of developing advanced computational design tools engineered to generate novel, 'new-to-nature' enzymes. These enzymes possess the capability to catalyze reactions previously unachievable and surpass the performance of existing counterparts. The company leverages these enzymes in a 'cell-free' manufacturing process, which effectively bypasses the inherent challenges of traditional cellular production, thereby reducing both production costs and development timelines. Enzymit's innovative platform is designed to convert atmospheric carbon into novel bio-polymers at an unprecedented cost efficiency, positioning the company to challenge major industry players with its groundbreaking technology and product offerings.
How much funding has Enzymit raised?
Enzymit has raised a total of $10M across 1 funding round:
Series A
$10M
Series A (2024): $10M with participation from First Star Ventures, Grove Ventures Ltd, Khosla Ventures, and Sapir Venture Partners
Key Investors in Enzymit
First Star Ventures
First Star Ventures is an investment firm focused on supporting visionary founders in advanced technologies like AI/ML, decentralization, edge computing, and techbio. They leverage their extensive experience and network to help hard computing tech startups scale rapidly.
Grove Ventures Ltd
Grove Ventures is a leading early-stage venture capital investment firm that partners with exceptional Israeli entrepreneurs building the future through deep technology. Headquartered in Tel Aviv-Yafo, Israel, they manage over half-a-billion dollars.
Khosla Ventures
Khosla Ventures is a venture capital firm that invests in a diverse range of technology companies, often focusing on disruptive innovations and early-stage ventures. They are known for their significant investments in sectors such as artificial intelligence, clean technology, and digital health.
What's next for Enzymit?
With this substantial infusion of capital, Enzymit is strategically positioned to accelerate its growth trajectory and solidify its market presence. The company's focus on developing cost-effective enzymatic processes for carbon conversion into bio-polymers, coupled with its cell-free manufacturing approach, indicates a strong commitment to sustainable and efficient industrial solutions. This funding will likely fuel further research and development, scale up production capabilities, and expand market penetration, enabling Enzymit to tackle significant environmental and industrial challenges while capitalizing on emerging opportunities in the bio-economy.
See full Enzymit company page
